Hodgkin Lymphoma
Conference Coverage
HIV free 30 months after stem cell transplant, is the London patient cured?
From the Journals
ECHELON-1 update: A+AVD bests ABVD in Hodgkin lymphoma
From the Journals
Adult survivors of childhood cancer are experiencing fewer major cardiac events
Reduced radiation exposure is a likely contributor to the improved cardiovascular outcomes.
From the Journals
Vitamin D deficiency appears to worsen survival in Hodgkin lymphoma
The researchers said vitamin D deficiency screening and replacement should be incorporated into future randomized clinical trials of Hodgkin...
From the Journals
Worse PFS when radiation is withheld in early-stage Hodgkin lymphoma
Patients negative for disease on PET scans after two chemotherapy cycles fared better with consolidation radiotherapy.
Conference Coverage
Cell count ratios appear to predict thromboembolism in lymphoma
AMSTERDAM – The findings mean clinicians can look to complete blood count for answers on thromboembolism risk.
From the Journals
Regimen shows promise as salvage for classical HL
Most patients studied responded to the regimen.
News
EC approves BV plus AVD for Hodgkin lymphoma
The approval for this indication is supported by the phase 3 ECHELON-1 trial.
From the Journals
Hidradenitis suppurativa linked to increased lymphoma risk
The risks of Hodgkin, non-Hodgkin, and cutaneous T-cell lymphoma were more common among males than females.
News
CMT provides survival benefit in young HL patients
Combined modality therapy (CMT) can improve survival in young patients with early stage Hodgkin lymphoma (HL), according to research published in...
News
Risk of second cancers in Hodgkin lymphoma survivors
Survivors of childhood Hodgkin lymphoma (HL) have a 14-fold higher risk of second cancers compared to the general population, according to new...